Cart
0

Biochips Market by Product (DNA Chip, Protein Chip, Lab-on-a-chip, and Others), Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, and Others), and End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes, and Others): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

Get 20% Free Customization In This Report
LI_184359
Pages: 235
Oct 2018 | 760 Views
 
Author's : Mayuri Srivastava and Onkar Sumant
Tables: 118
Charts: 45
 

Biochips Market Overview :

The global biochips market was valued at $9,037 million in 2017, and is projected to reach $21,419 million by 2025 at a CAGR of 11.2% from 2018 to 2025. Biochip is a miniaturized medical device used in molecular laboratories to carry out several biochemical reactions simultaneously. It can rapidly screen a number of biological analytes for an array of applications such as disease diagnosis and detection of hazardous biological agents in a system. It is designed on the basis of microarray and microfluidic technologies, among which digital microfluid biochip is highly efficient, and has gained significant popularity in the biochemical field.

Get more information on this report: Request Sample Pages

Market dynamics

Increase in prevalence of cancer, immunological disorders, and viral infections majorly drives the growth of the global biochips market. Other factors that boost the market growth include rise in geriatric population, increase in number of biochip applications, and high adoption of personalized medications. However, factors such as high cost of biochip and lack of knowledge about it majorly in emerging nations hamper the market growth. Conversely, rise in R&D investment as well as government funding and high potential in untapped markets in emerging economies are expected to provide lucrative growth opportunities for the market.

Market segmentation

The global biochips market is segmented based on product, application, end user, and region. On the basis of product, the market is divided into DNA chip, protein chip, lab-on-a-chip, and others. The DNA chip segment accounted for the largest market share in 2017, and is expected to continue this trend throughout the forecast period, owing to high adoption of DNA chip products. However, protein chip segment is anticipated to grow at a significant CAGR of 12.9% during the forecast period.

Get more information on this report: Request Sample Pages

The applications covered in the study include drug discovery & development, disease diagnostics, genomics, proteomics, agriculture, and others.

Get more information on this report: Request Sample Pages

Depending on end user, the market is categorized into biotechnology & pharmaceutical companies, hospitals & diagnostics centers, academic & research institutes, and others. Among these, the biotechnology & pharmaceutical companies segment held maximum share in 2017, and is anticipated to grow at a significant CAGR of 10.7%. However, the academic & research institutes segment is expected to register high growth rate during the forecast period.

Region wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA. North America held the largest share of the market in 2017, followed by Europe. On the other hand, Asia-Pacific is anticipated to dominate the market during the analysis period, owing to presence of large population base, increase in disposable income, and improvement in patient awareness about biochips.

Get more information on this report: Request Sample Pages

The key players of this market include bioMérieux SA, Bio-Rad Laboratories, Inc., Fluidigm Corporation, F. Hoffmann-La Roche AG, HORIBA, Ltd., Illumina, Inc., PerkinElmer, Inc., QIAGEN N.V., Randox Laboratories Ltd., and Thermo Fisher Scientific Inc.

Other players (these players are not profiled in the report, however, the same can be included on request) in the value chain include Micronit Microfluidics BV, OriGene Technologies, Inc., ANALIS SA/NV, AMS Alliance, and Dynamic Biosensors GmbH.

Key Benefits for Biochips Market :

  • The study provides an in-depth analysis of the global biochips market along with current trends and future estimations from 2018 to 2025 to elucidate the imminent investment pockets.

  • Comprehensive analysis of factors that drive and restrict the market growth is provided.

  • Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.

  • Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

Biochips Key market segments :

By Product

  • DNA Chip

  • Protein Chip

  • Lab-on-a-chip

  • Others

By Application

  • Drug Discovery & Development

  • Disease Diagnostics

  • Genomics

  • Proteomics

  • Agriculture

  • Others

By End User

  • Biotechnology & Pharmaceutical Companies

  • Hospitals & Diagnostics Centers

  • Academic & Research Institutes

  • Others

By Region

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific

  • LAMEA

    • Brazil

    • Saudi Arabia

    • South Africa

    • Rest of LAMEA

 

Chapter: 1: INTRODUCTION

1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments

1.3.1. List of key players profiled in the report

1.4. Research Methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets

3.3. Top player positioning, 2017 (%)
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in the incidence life threatening disorders
3.4.1.2. Rise in geriatric population
3.4.1.3. High demand of personalized medicines
3.4.1.4. Large number of biochips applications

3.4.2. Restraints

3.4.2.1. High cost of biochips
3.4.2.2. Lack of awareness in developing countries

3.4.3. Opportunity

3.4.3.1. Untapped market opportunities in the developing regions

3.4.4. Impact analyses

Chapter: 4: BIOCHIPS MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast, by product

4.2. DNA chip

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country

4.3. Protein chip

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

4.4. Lab-on-chip

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country

4.5. Others

4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country

Chapter: 5: BIOCHIPS MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast, by revenue

5.2. Drug discovery and development

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country

5.3. Disease diagnostics

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

5.4. Genomics

5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country

5.5. Proteomics

5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country

5.6. Agriculture

5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country

5.7. Other applications

5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by country

Chapter: 6: BIOCHIPS MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Biotechnology and pharmaceutical companies

6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country

6.3. Hospitals & diagnostics centers

6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country

6.4. Academic and research institutes

6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country

6.5. Other end users

6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by country

Chapter: 7: BIOCHIPS MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America market size and forecast, by country

7.2.2.1. U.S.

7.2.2.1.1. U.S. market size and forecast, by product
7.2.2.1.2. U.S. market size and forecast, by application
7.2.2.1.3. U.S. market size and forecast, by end user

7.2.2.2. Canada

7.2.2.2.1. Canada market size and forecast, by product
7.2.2.2.2. Canada market size and forecast, by application
7.2.2.2.3. Canada market size and forecast, by end user

7.2.2.3. Mexico

7.2.2.3.1. Mexico market size and forecast, by product
7.2.2.3.2. Mexico market size and forecast, by application
7.2.2.3.3. Mexico market size and forecast, by end user

7.2.3. North America market size and forecast, by product
7.2.4. North America market size and forecast, by application
7.2.5. North America market size and forecast, by end user

7.3. Europe

7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe biochips market, by country

7.3.2.1. Germany

7.3.2.1.1. Germany market size and forecast, by product
7.3.2.1.2. Germany market size and forecast, by application
7.3.2.1.3. Germany market size and forecast, by end user

7.3.2.2. France

7.3.2.2.1. France market size and forecast, by product
7.3.2.2.2. France market size and forecast, by application
7.3.2.2.3. France market size and forecast, by end user

7.3.2.3. UK

7.3.2.3.1. UK market size and forecast, by product
7.3.2.3.2. UK market size and forecast, by application
7.3.2.3.3. UK market size and forecast, by end user

7.3.2.4. Italy

7.3.2.4.1. Italy market size and forecast, by product
7.3.2.4.2. Italy market size and forecast, by application
7.3.2.4.3. Italy market size and forecast, by end user

7.3.2.5. Spain

7.3.2.5.1. Spain market size and forecast, by product
7.3.2.5.2. Spain market size and forecast, by application
7.3.2.5.3. Spain market size and forecast, by end user

7.3.2.6. Rest of Europe

7.3.2.6.1. Rest of Europe market size and forecast, by product
7.3.2.6.2. Rest of Europe market size and forecast, by application
7.3.2.6.3. Rest of Europe market size and forecast, by end user

7.3.3. Europe market size and forecast, by product
7.3.4. Europe market size and forecast, by application
7.3.5. Europe market size and forecast, by end user

7.4. Asia-Pacific

7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific market size and forecast, by country

7.4.2.1. Japan

7.4.2.1.1. Japan market size and forecast, by product
7.4.2.1.2. Japan market size and forecast, by application
7.4.2.1.3. Japan market size and forecast, by end user

7.4.2.2. China

7.4.2.2.1. China market size and forecast, by product
7.4.2.2.2. China market size and forecast, by application
7.4.2.2.3. China market size and forecast, by end user

7.4.2.3. India

7.4.2.3.1. India market size and forecast, by product
7.4.2.3.2. India market size and forecast, by application
7.4.2.3.3. India market size and forecast, by end user

7.4.2.4. Australia

7.4.2.4.1. Australia market size and forecast, by product
7.4.2.4.2. Australia market size and forecast, by application
7.4.2.4.3. Australia market size and forecast, by end user

7.4.2.5. South Korea

7.4.2.5.1. South Korea market size and forecast, by product
7.4.2.5.2. South Korea market size and forecast, by application
7.4.2.5.3. South Korea market size and forecast, by end user

7.4.2.6. Rest of Asia-Pacific

7.4.2.6.1. Rest of Asia-Pacific market size and forecast, by product
7.4.2.6.2. Rest of Asia-Pacific market size and forecast, by application
7.4.2.6.3. Rest of Asia-Pacific market size and forecast, by end user

7.4.3. Asia-Pacific market size and forecast, by product
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by end user

7.5. LAMEA

7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA market size and forecast, by country

7.5.2.1. Brazil

7.5.2.1.1. Brazil market size and forecast, by product
7.5.2.1.2. Brazil market size and forecast, by application
7.5.2.1.3. Brazil market size and forecast, by end user

7.5.2.2. Saudi Arabia

7.5.2.2.1. Saudi Arabia market size and forecast, by product
7.5.2.2.2. Saudi Arabia market size and forecast, by application
7.5.2.2.3. Saudi Arabia market size and forecast, by end user

7.5.2.3. South Africa

7.5.2.3.1. South Arica market size and forecast, by product
7.5.2.3.2. South Arica market size and forecast, by application
7.5.2.3.3. South Arica market size and forecast, by end user

7.5.2.4. Rest of LAMEA

7.5.2.4.1. Rest of LAMEA market size and forecast, by product
7.5.2.4.2. Rest of LAMEA market size and forecast, by application
7.5.2.4.3. Rest of LAMEA market size and forecast, by end user

7.5.3. LAMEA market size and forecast, by product
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by end user

Chapter: 8: COMPANY PROFILES

8.1. bioMrieux S.A.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product Portfolio
8.1.5. Business performance

8.2. Bio-Rad Laboratories, Inc.

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance

8.3. F. Hoffmann-La Roche Ltd.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance

8.4. Fluidigm Corporation

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product Portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments

8.5. Illumina, Inc.

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance

8.6. HORIBA, Ltd.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance

8.7. PerkinElmer, Inc.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product Portfolio
8.7.5. Business performance

8.8. QIAGEN N.V.

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance

8.9. Randox Laboratories Ltd.

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio

8.10. Thermo Fisher Scientific Inc.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments

LIST OF TABLES

TABLE 01. GLOBAL BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 02. DNA CHIP MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 03. PROTEIN CHIP MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 04. LAB-ON-CHIP MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 05. OTHERS BIOCHIPS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 06. GLOBAL BIOCHIPS MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 07. BIOCHIPS MARKET FOR DRUS DISCOVERY AND DEVELOPMENT, BY REGION, 2017-2025 ($MILLION)
TABLE 08. BIOCHIPS MARKET FOR DISEASE DIAGNOSTICS, BY REGION, 2017-2025 ($MILLION)
TABLE 09. BIOCHIPS MARKET FOR GENOMICS, BY REGION, 2017-2025 ($MILLION)
TABLE 10. BIOCHIPS MARKET FOR PROTEOMICS, BY REGION, 2017-2025 ($MILLION)
TABLE 11. BIOCHIPS MARKET FOR AGRICULTURE, BY REGION, 2017-2025 ($MILLION)
TABLE 12. BIOCHIPS MARKET FOR OTHER APPLICATIONS, BY REGION, 2017-2025 ($MILLION)
TABLE 13. GLOBAL BIOCHIPS MARKET REVENUE, BY END USER, 2017-2025 ($MILLION)
TABLE 14. BIOCHIPS MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2017-2025 ($MILLION)
TABLE 15. BIOCHIPS MARKET FOR HOSPITALS & DIAGNOSTICS CENTERS, BY REGION, 2017-2025 ($MILLION)
TABLE 16. BIOCHIPS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2017-2025 ($MILLION)
TABLE 17. BIOCHIPS MARKET FOR OTHER END USERS, BY REGION, 2017-2025 ($MILLION)
TABLE 18. BIOCHIPS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 19. NORTH AMERICA BIOCHIPS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 20. U.S. BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 21. U.S. BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 22. U.S. BIOCHIPS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 23. CANADA BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 24. CANADA BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 25. CANADA BIOCHIPS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 26. MEXICO BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 27. MEXICO BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 28. MEXICO BIOCHIPS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 29. NORTH AMERICA BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 30. NORTH AMERICA BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 31. NORTH AMERICA BIOCHIPS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 32. EUROPE BIOCHIPS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 33. GERMANY BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 34. GERMANY BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 35. GERMANY BIOCHIPS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 36. FRANCE BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 37. FRANCE BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 38. FRANCE BIOCHIPS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 39. UK BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 40. UK BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 41. UK BIOCHIPS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 42. ITALY BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 43. ITALY BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 44. ITALY BIOCHIPS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 45. SPAIN BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 46. SPAIN BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 47. SPAIN BIOCHIPS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 48. REST OF EUROPE BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 49. REST OF EUROPE BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 50. REST OF EUROPE BIOCHIPS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 51. EUROPE BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 52. EUROPE BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 53. EUROPE BIOCHIPS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 54. ASIA-PACIFIC BIOCHIPS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 55. JAPAN BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 56. JAPAN BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 57. JAPAN BIOCHIPS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 58. CHINA BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 59. CHINA BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 60. CHINA BIOCHIPS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 61. INDIA BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 62. INDIA BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 63. INDIA BIOCHIPS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 64. AUSTRALIA BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 65. AUSTRALIA BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 66. AUSTRALIA BIOCHIPS MARKET, BY END USER, 20172025 ($MILLION)
TABLE 67. SOUTH KOREA BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 68. SOUTH KOREA BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 69. SOUTH KOREA BIOCHIPS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC BIOCHIPS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 73. ASIA-PACIFIC BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 74. ASIA-PACIFIC BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 75. ASIA-PACIFIC BIOCHIPS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 76. LAMEA BIOCHIPS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 77. BRAZIL BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 78. BRAZIL BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 79. BRAZIL BIOCHIPS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 80. SAUDI ARABIA BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 81. SAUDI ARABIA BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 82. SAUDI ARABIA BIOCHIPS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 83. SOUTH ARICA BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 84. SOUTH ARICA BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 85. SOUTH ARICA BIOCHIPS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 86. REST OF LAMEA BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 87. REST OF LAMEA BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 88. REST OF LAMEA BIOCHIPS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 89. LAMEA BIOCHIPS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 90. LAMEA BIOCHIPS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 91. LAMEA BIOCHIPS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 92. BIOMRIEUX S.A.: COMPANY SNAPSHOT
TABLE 93. BIOMRIEUX S.A.: OPERATING SEGMENTS
TABLE 94. BIOMRIEUX S.A.: PRODUCT PORTFOLIO
TABLE 95. BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 96. BIO-RAD LABORATORIES, INC.: BUSINESS SEGMENTS
TABLE 97. BIO-RAD LABORATORIES, INC.: PRODUCT PORTFOLIO
TABLE 98. ROCHE: COMPANY SNAPSHOT
TABLE 99. ROCHE: OPERATING SEGMENTS
TABLE 100. ROCHE: PRODUCT PORTFOLIO
TABLE 101. FLUIDIGM CORPORATION: COMPANY SNAPSHOT
TABLE 102. FLUIDIGM CORPORATION: PRODUCT PORTFOLIO
TABLE 103. ILLUMINA, INC.: COMPANY SNAPSHOT
TABLE 104. ILLUMINA, INC.: OPERATING SEGMENTS
TABLE 105. ILLUMINA, INC.: PRODUCT PORTFOLIO
TABLE 106. HORIBA: COMPANY SNAPSHOT
TABLE 107. HORIBA: BUSINESS SEGMENTS
TABLE 108. HORIBA: PRODUCT PORTFOLIO
TABLE 109. PERKINELMER, INC.: COMPANY SNAPSHOT
TABLE 110. PERKINELMER, INC.: OPERATING SEGMENTS
TABLE 111. PERKINELMER, INC.: PRODUCT PORTFOLIO
TABLE 112. QIAGEN N.V.: COMPANY SNAPSHOT
TABLE 113. QIAGEN N.V.: PRODUCT PORTFOLIO
TABLE 114. RANDOX LABORATORIES LTD.: COMPANY SNAPSHOT
TABLE 115. RANDOX LABORATORIES LTD.: DIVISIONS
TABLE 116. RANDOX LABORATORIES LTD.: PRODUCT PORTFOLIO
TABLE 117. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 118. THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
TABLE 119. RANDOX LABORATORIES LTD.: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. GLOBAL BIOCHIPS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP PLAYER POSITIONING, 2017
FIGURE 04. NUMBER OF NEW CASES OF CANCER PER 100,000 PEOPLE, 2018
FIGURE 05. IMPACT ANALYSES
FIGURE 06. COMPARATIVE COUNTRY ANALYSIS OF DNA CHIP MARKET, 2017 & 2025 (%)
FIGURE 07. COMPARATIVE COUNTRY ANALYSIS OF PROTEIN CHIP MARKET, 2017 & 2025 (%)
FIGURE 08. COMPARATIVE COUNTRY ANALYSIS OF LAB-ON-CHIP MARKET, 2017 & 2025 (%)
FIGURE 09. COMPARATIVE COUNTRY ANALYSIS OF OTHER BIOCHIPS MARKET, 2017 & 2025 (%)
FIGURE 10. COMPARATIVE COUNTRY ANALYSIS OF BIOCHIPS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, 2017 & 2025 (%)
FIGURE 11. COMPARATIVE COUNTRY ANALYSIS OF BIOCHIPS MARKET FOR DISEASE DIAGNOSTICS, 2017 & 2025 (%)
FIGURE 12. COMPARATIVE COUNTRY ANALYSIS OF BIOCHIPS MARKET FOR GENOMICS, 2017 & 2025 (%)
FIGURE 13. COMPARATIVE COUNTRY ANALYSIS OF BIOCHIPS MARKET FOR PROTEOMICS, 2017 & 2025 (%)
FIGURE 14. COMPARATIVE COUNTRY ANALYSIS OF BIOCHIPS MARKET FOR AGRICULTURE, 2017 & 2025 (%)
FIGURE 15. COMPARATIVE COUNTRY ANALYSIS OF BIOCHIPS MARKET FOR OTHER APPLICATIONS, 2017 & 2025 (%)
FIGURE 16. COMPARATIVE COUNTRY ANALYSIS OF BIOCHIPS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2017 & 2025 (%)
FIGURE 17. COMPARATIVE COUNTRY ANALYSIS OF BIOCHIPS MARKET FOR HOSPITALS AND DIAGNOSTICS CENTERS, 2017 & 2025 (%)
FIGURE 18. COMPARATIVE COUNTRY ANALYSIS OF BIOCHIPS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, 2017 & 2025 (%)
FIGURE 19. COMPARATIVE COUNTRY ANALYSIS OF BIOCHIPS MARKET FOR OTHER END USERS, 2017 & 2025 (%)
FIGURE 20. BIOMRIEUX S.A.: NET SALES, 2015-2017 ($MILLION)
FIGURE 21. BIOMRIEUX S.A.: NET SALES SHARE BY SEGMENT, 2017 (%)
FIGURE 22. BIOMRIEUX S.A.: NET SALES SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 23. BIO-RAD LABORATORIES, INC.: NET SALES, 2015-2017 ($MILLION)
FIGURE 24. BIO-RAD LABORATORIES, INC.: REVENUE SHARE, BY SEGMENT, 2017 (%)
FIGURE 25. BIO-RAD LABORATORIES, INC.: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)
FIGURE 26. ROCHE: NET SALES, 2015-2017 ($MILLION)
FIGURE 27. ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 28. ROCHE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 29. FLUIDIGM CORPORATION: NET SALES, 2015-2017 ($MILLION)
FIGURE 30. FLUIDIGM CORPORATION: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)
FIGURE 31. ILLUMINA, INC.: NET SALES, 2015-2017 ($MILLION)
FIGURE 32. ILLUMINA, INC.: NET SALES, BY SEGMENT, 2017 (%)
FIGURE 33. ILLUMINA, INC.: NET SALES, BY GEOGRAPHY, 2017 (%)
FIGURE 34. HORIBA: NET SALES, 2015-2017 ($MILLION)
FIGURE 35. HORIBA: NET SALES, BY SEGMENT, 2017 (%)
FIGURE 36. HORIBA: NET SALES, BY GEOGRAPHY, 2017 (%)
FIGURE 37. PERKINELMER, INC.: NET SALES, 2015-2017 ($MILLION)
FIGURE 38. PERKINELMER, INC.: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 39. PERKINELMER, INC.: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 40. QIAGEN N.V.: NET SALES, 2015-2017 ($MILLION)
FIGURE 41. QIAGEN N.V.: REVENUE SHARE BY PRODUCT SEGMENT, 2017 (%)
FIGURE 42. QIAGEN N.V.: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 43. THERMO FISHER SCIENTIFIC INC.: REVENUE, 2015-2017 ($MILLION)
FIGURE 44. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 45. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

 

 

Biochip is a small specimen chip or tray on which biological molecules are placed for biotechnological analysis. It is designed based on microarrays or microfabrication technologies. It is made up of glass, silicon, polymers, and aluminum material on which individual biological molecules such as NA, RNA, peptides, proteins, are immobilized on the surface. On the basis of biological molecules that are immobilized, biochips are differentiated into various categories such as DNA chips, protein chips, lab-on-chip, and others. Biochips are widely used in multiple medical and pharmaceutical applications as well as in the food industry and environmental safety procedures.

The adoption of biochips is expected to increase in the near future, owing to high prevalence rate of cancer, immunological diseases, and viral infections; rise in geriatric population; increase in biochip applications; and surge in demand for personalized medicines. These devices have gained significant popularity among patients as well as healthcare providers, as they are easy to operate and offer a host of benefits. However, high cost of biochips and lack of knowledge about biochips in emerging nations hamper the market growth.

North America witnessed the highest sales of biochip products, owing to increased awareness toward microarrays-based products and heavy expenditure by the government on improving healthcare, followed by Europe and Asia-Pacific. In addition, manufacturers and distributors of biochip products have focused on expanding their presence in emerging economies, which is expected to drive the market growth.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Biochips Market

  • Online Only
  • $3456
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo